Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17690167 | 0.94 | ALK (0.32) | GPR3ALDH1A1POLBMAPTTDP1 | |
| SCHEMBL21141229 | 0.93 | ALDH1A1 (0.34) | GPR3ALDH1A1POLBMAPTTDP1 | |
| SCHEMBL25145390 | 0.91 | — | — | |
| SCHEMBL16544679 | 0.89 | ALK (0.30) | ALK | |
| SCHEMBL21141227 | 0.89 | ALOX5 (0.34) | PDK2 | |
| SCHEMBL21141156 | 0.89 | GPR3 (0.32) | GPR3ALDH1A1POLBMAPTTDP1 | |
| SCHEMBL26060102 | 0.88 | — | — | |
| SCHEMBL25889821 | 0.88 | MEN1 (0.31) | POLBMAPTTDP1 | |
| SCHEMBL25145448 | 0.88 | — | — | |
| SCHEMBL17690144 | 0.88 | ALDH1A1 (0.33) | GPR3ALDH1A1POLBMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512038-B2 | Tetraphenylene triarylamine compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-11-29 | — | — | US | disclosed |
| US-20190185412-A1 | TETRAPHENYLENE TRIARYLAMINE COMPOUNDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512038-B2 | Tetraphenylene triarylamine compounds | OCIAD2, OCIAD1, SLC7A5 | GPR3 1825/4885ALDH1A1 2637/4885POLB 916/4885 |
| US-20190185412-A1 | TETRAPHENYLENE TRIARYLAMINE COMPOUNDS | OCIAD2, OCIAD1, SLC7A5 | GPR3 1825/4885ALDH1A1 2637/4885POLB 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.